Kyntra Bio, Inc. (KYNB) — Free Cash Flow Generation Index
Latest as of June 2025:
1.00x
Kyntra Bio, Inc. (KYNB) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $12.67 Million represents 1% of operating cash flow ($12.68 Million). Check how resilient are Kyntra Bio, Inc.'s assets to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
$12.67 Million
USD
Operating Cash Flow
$12.68 Million
USD
Capital Expenditures
$13.00K
USD
Kyntra Bio, Inc. Free Cash Flow Generation Index (2013–2020)
Historical FCF Generation Index trend for Kyntra Bio, Inc. across 4 annual periods. Explore Kyntra Bio, Inc. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Kyntra Bio, Inc. (2013–2020)
Year-by-year Free Cash Flow Generation Index for Kyntra Bio, Inc.. For the full cash flow conversion analysis, see KYNB operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.95x | $77.61 Million | $81.60 Million | $3.99 Million | ▲ +15.4% |
| 2016 | 0.82x | $5.86 Million | $7.11 Million | $1.25 Million | ▲ +29.2% |
| 2014 | 0.64x | $14.30 Million | $22.41 Million | $8.12 Million | ▼ -13.5% |
| 2013 | 0.74x | $19.11 Million | $25.92 Million | $6.81 Million | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).